A Study to Learn About Salanersen's (BIIB115) Effects on Movement and Its Safety When Given Before Symptoms Appear in Babies With Genetically Diagnosed Spinal Muscular Atrophy (SMA) | MicrobiomeTrials
A Study to Learn About Salanersen's (BIIB115) Effects on Movement and Its Safety When Given Before Symptoms Appear in Babies With Genetically Diagnosed Spinal Muscular Atrophy (SMA)
RecruitingPHASE3INTERVENTIONAL
Trial Details
Start: 2026-04-28Est. Completion: 2028-11-28
Enrollment target: 30 participants
Locations
Ann and Robert H Lurie Childrens Hospital of Chicago, Chicago, Illinois, United States
Neurology Rare Disease Center, Flower Mound, Texas, United States
Childrens Hospital of the Kings Daughter Norfolk, Norfolk, Virginia, United States
Childrens Hospital of Fudan University_Shanghai, Shanghai, China